A decade in gastric cancer curative surgery: Evidence of progress (1999-2009)

World J Gastrointest Surg. 2012 Mar 27;4(3):45-54. doi: 10.4240/wjgs.v4.i3.45.

Abstract

To investigate the progress in evidence-based surgical treatment of non-metastatic gastric cancer, we reviewed the last ten years' literature. The data used in this review were identified by searches made on MEDLINE, Current Contents, PubMed, and other references taken from relevant original articles (on prospective and retrospective studies) concerning gastric cancer surgery. Only papers published in English between January 1999 and December 2009 were selected. Data from ongoing studies were obtained in December 2009, from the trials registry of the United States National Institutes of Health (http://www.clinicaltrial.gov). The citations list was presented according to evidence based relevance (i.e., randomized controlled trials, prospective studies, retrospective series). In the last ten years, many challenges have been faced relating to the extension of gastric resection and nodal dissection as well as surgical timing, but we found only limited evidence, regardless of latitude of study. The ongoing phase-III trials may provide answers that will be valid for the coming decades, and which may bring definitive answers for the currently unresolved questions.

Keywords: D2 lymphadenectomy; Endoscopic treatment; Evidence-based surgery; Gastric cancer; Laparoscopic gastrectomy; Neoadjuvant therapy.